University Hospital Ghent
Ghent, 9000, Belgium
NCT Number: NCT00134290
This is a study to:
* Determine the difference between strong hypo-energetic "standard diet advice" and modest hypo-energetic "personal diet advice"; and * Determine the influence of insulin-insensitivity on obesity and weight reduction by treating patients with metformin or placebo.
Looking for future studies?
Notify Me20 year–55 year
All sexes
Interventional
Phase 4
Ghent, 9000, Belgium
The aim of the present study was to determine what the difference is of a strong hypo-energetic "standard diet advice" and a modest hypo-energetic "personal diet advice" which was determined by the energy needs of a person as calculated with a combination of basal metabolic rate (BMR) and physical activity level (PAL) on weight loss and insulin sensitivity.
Secondly, this study wanted to determine what the influence is of insulin-insensitivity on obesity and weight reduction by treating the patients with metformin or placebo. The subjects were therefore randomised into two double blinded groups receiving either metformin (2 x 850 mg per day) or placebo in combination with a moderate energy restriction and a exercise regimen of 30 minutes per day for 1 year.
Treatment effects of both diets and the effect of metformin on weight reduction and insulin sensitivity were determined after a treatment period of 20 and 52 weeks.
Insulin sensitivity was quantified using the homeostasis model assessment (HOMA) and the OGTT. Body composition was determined with the bioelectrical impedance method.
Blood was also drawn for hormonal and biochemical analyses after 20 and 52 weeks of treatment. Furthermore, the patients had to fill out a 3-day food diary at baseline, after 20 weeks and after 52 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Hospital, Ghent
Other
The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06259435
Body Weight, Glucose Metabolism Disorders
Baton Rouge, Louisiana, United States
View Trial DetailsNCT05558488
Acid-Base Imbalance, Acidosis
Poznan, Greater Poland Voivodeship, Poland
View Trial DetailsNCT02322294
Body Weight, Glucose Metabolism Disorders
London, Ontario, Canada
View Trial DetailsNCT00935922
Blood Glucose, Body Weight
Mather, California, United States
View Trial Details